Ubiquitin-C Protein (UBC)
Introduction Ubiquitin C Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-protein"> <div class="infobox-header">Ubiquitin-C</div> <table> <tr><th>Full Name</th><td>Ubiquitin C</td></tr> <tr><th>Gene</th><td>[UBC](/genes/ubc)</td></tr> <tr><th>UniProt ID</th><td>[P0C0U5](https://www.uniprot.org/uniprot/P0C0U5)</td></tr> <tr><th>PDB ID</th><td>[1UBQ](https://www.ebi.ac.uk/pdbe/1UBQ)</td></tr> <tr><th>Molecular Weight</th><td>8.5 kDa (per ubiquitin monomer)</td></tr> <tr><th>Subcellular Localization</th><td>Cytoplasm, Nucleus</td></tr> <tr><th>Protein Family</th><td>Ubiquitin family</td></tr> <tr><th>Aliases</th><td>Polyubiquitin C, UBC</td></tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer-disease" style="color:#ef9a9a">ALZHEIMER DISEASE</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">AMYOTROPHIC LATERAL SCLEROSIS</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">2864 edges</a></td> </tr> </table> </div>
Overview ...
Ubiquitin-C Protein (UBC)
Introduction Ubiquitin C Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-protein"> <div class="infobox-header">Ubiquitin-C</div> <table> <tr><th>Full Name</th><td>Ubiquitin C</td></tr> <tr><th>Gene</th><td>[UBC](/genes/ubc)</td></tr> <tr><th>UniProt ID</th><td>[P0C0U5](https://www.uniprot.org/uniprot/P0C0U5)</td></tr> <tr><th>PDB ID</th><td>[1UBQ](https://www.ebi.ac.uk/pdbe/1UBQ)</td></tr> <tr><th>Molecular Weight</th><td>8.5 kDa (per ubiquitin monomer)</td></tr> <tr><th>Subcellular Localization</th><td>Cytoplasm, Nucleus</td></tr> <tr><th>Protein Family</th><td>Ubiquitin family</td></tr> <tr><th>Aliases</th><td>Polyubiquitin C, UBC</td></tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer-disease" style="color:#ef9a9a">ALZHEIMER DISEASE</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">AMYOTROPHIC LATERAL SCLEROSIS</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">2864 edges</a></td> </tr> </table> </div>
Overview Ubiquitin-C (UBC) is the second major polyubiquitin gene in humans (alongside UBB) that provides ubiquitin monomers for the [ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system) and various ubiquitin-dependent cellular processes[@hershko2023]. The UBC gene encodes a polyubiquitin precursor that is processed to generate multiple ubiquitin molecules essential for cellular homeostasis[@komander2024].
UBC is expressed ubiquitously at high levels in all tissues, including the brain, where it is critical for maintaining cellular protein quality control through the UPS and regulating numerous signaling pathways. The ubiquitin code—combinations of ubiquitin chain types, lengths, and linkages—determines the fate of modified proteins[@yau2023].
Structure
Primary Structure
Gene structure : 9 ubiquitin repeats in tandem
Monomer size : 76 amino acids, 8.5 kDa
Processing : Co-translational by deubiquitinating enzymes
Polymerization : Multiple chain types possible
Ubiquitin Domain
Fold : β-grasp (β1-β5, one α-helix)
Key residues :
Gly76 (C-terminal, for conjugation)
Lys6, Lys11, Lys27, Lys29, Lys33, Lys48, Lys63 (chain building)
Met1 (linear chains)
Chain Types and Functions | Linkage | Function |
|---------|----------|
| K48 | Proteasomal degradation |
| K63 | Signaling, endocytosis, DNA repair |
| K27 | [Autophagy](/entities/autophagy), stress response |
| K6 | DNA damage, mitophagy |
| K11 | Cell cycle, proteasome |
| K33 | Synaptic function |
| M1 | Linear chains, [NF-κB](/entities/nf-kb) |
Biological Function
Protein Degradation
Polyubiquitination : E1-E2-E3 cascade
Proteasome recognition : K48-linked chains
Degradation : Unfolding and proteolysis
Signaling Regulation
NF-κB activation : K63 and M1 chains
Wnt signaling : K27, K33
[mTOR](/mechanisms/mtor-signaling-pathway) pathway : Various linkages
Cellular Homeostasis
Protein quality control
Cell cycle regulation
DNA repair
Organelle quality control
Role in Neurodegeneration
Alzheimer's Disease
Aggregate ubiquitination : Neurofibrillary tangles
Proteasome inhibition : Contributes to pathology
Synaptic dysfunction : Altered ubiquitination
Therapeutic target : Enhance clearance[@tai2022]
Parkinson's Disease
Lewy bodies : Ubiquitinated
Parkin E3 ligase : Mutations cause early-onset PD
PINK1-Parkin pathway : Mitophagy
[α-synuclein](/proteins/alpha-synuclein) clearance : UPS-dependent
Huntington's Disease
[Huntingtin](/proteins/huntingtin) aggregates : Ubiquitinated
Transcription : Dysregulated ubiquitination
Proteasome function : Impaired
ALS
[TDP-43](/mechanisms/tdp-43-proteinopathy) pathology : Ubiquitinated inclusions
Proteostasis : Impaired protein clearance
RNA metabolism : Altered
Therapeutic Implications
Strategies
Proteasome modulators : Enhance activity
DUB inhibitors/activators : Modulate ubiquitination
Autophagy inducers : Alternative clearance
E3 ligase modulators : Restore function
Ubiquitin mutants : Linkage-specific probes
Proteasome inhibitors : Bortezomib, carfilzomib
DUB inhibitors : USP7, USP30 inhibitors
Cross-Links
[UBC Gene](/genes/ubc) — Gene page
[Ubiquitin](/proteins/ubiquitin-protein) — General ubiquitin
[Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system) — UPS
[Alzheimer's Disease](/diseases/alzheimers-disease) — AD
[Parkinson's Disease](/diseases/parkinsons-disease) — PD
Background The study of Ubiquitin C Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
[Proteasome in Neurodegeneration](/mechanisms/ubiquitin-proteasome-system)
[Protein Aggregation](/mechanisms/protein-aggregation-neurodegeneration)
[Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system)
External Links
[UniProt](https://www.uniprot.org/)
[NCBI Protein Database](https://www.ncbi.nlm.nih.gov/protein/)
References
[Hershko A, Ciechanover A, The ubiquitin system: From basic mechanisms to human disease (2023)](https://doi.org/10.1146/annurev-biochem-052521-034847)
[Komander D, et al, The ubiquitin code: Expanding the complexity of ubiquitin modifications (2024)](https://doi.org/10.1038/s41580-024-00693-6)
[Yau RG, et al, Assembly and functions of the ubiquitin code (2023)](https://doi.org/10.1016/j.molcel.2023.05.016)
[Tai HC, Schuman EM, Ubiquitin in neuronal function and dysfunction (2022)](https://doi.org/10.1038/s41583-022-00604-6)
Show full description